The BAF Complex Interacts with Pax6 in Adult Neural Progenitors to Establish a Neurogenic Cross-Regulatory Transcriptional Network  by Ninkovic, Jovica et al.
Cell Stem Cell
ArticleThe BAF Complex Interacts with Pax6 in Adult
Neural Progenitors to Establish a Neurogenic
Cross-Regulatory Transcriptional Network
Jovica Ninkovic,1,4 Andrea Steiner-Mezzadri,1 Melanie Jawerka,4 Umut Akinci,5 Giacomo Masserdotti,1,4
Stefania Petricca,1 Judith Fischer,1 Alexander von Holst,7 Johanes Beckers,3,8 Chichung D. Lie,2,9 David Petrik,10
Erik Miller,12 Jiong Tang,12 Jiang Wu,11 Veronique Lefebvre,13 Jeroen Demmers,6 Amelia Eisch,10 Daniel Metzger,14
Gerald Crabtree,12 Martin Irmler,3 Raymond Poot,5 and Magdalena Go¨tz1,4,15,*
1Institute for Stem Cell Research
2Institute of Developmental Genetics
3Institute of Experimental Genetics
Helmholtz Centre Munich German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany
4Physiological Genomics, Medical Faculty, University of Munich, Schillerstrasse 46, 80633 Munich, Germany
5Department of Cell Biology
6Proteomics Center
Erasmus MC, Dr. Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
7Department of Anatomy andCell Biology, Heidelberg University, Im Neuenheimer Feld 307 and Interdisciplinary Center Neurosciences (IZN),
69120 Heidelberg, Germany
8Center of Life and Food Sciences Weihenstephan, Technical University Munich, 85354 Freising, Germany
9Institute of Biochemistry, Emil Fischer Center, University Erlangen-Nu¨rnberg, 91054 Erlangen, Germany
10Department of Psychiatry
11Department of Physiology and Developmental Biology
UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9070, USA
12Howard Hughes Medical Institute, Beckman Center B211, 279 Campus Drive, Stanford University School of Medicine, Stanford,
CA 94305-5323, USA
13Department of Cell Biology (NC10), Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA
14Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire (IGBMC), INSERM U964 / CNRS UMR 7104 / Universite´ de Strasbourg,
67404 Illkirch, CEDEX, France
15Munich Cluster for Systems Neurology (EXC 1010 SyNergy), Ludwig Maximilian University of Munich, 80539 Munich, Germany
*Correspondence: magdalena.goetz@helmholtz-muenchen.de
http://dx.doi.org/10.1016/j.stem.2013.07.002SUMMARY
Numerous transcriptional regulators of neurogene-
sis have been identified in the developing and adult
brain, but how neurogenic fate is programmed at
the epigenetic level remains poorly defined. Here,
we report that the transcription factor Pax6 directly
interacts with the Brg1-containing BAF complex
in adult neural progenitors. Deletion of either Brg1
or Pax6 in the subependymal zone (SEZ) causes
the progeny of adult neural stem cells to convert
to the ependymal lineage within the SEZ while
migrating neuroblasts convert to different glial line-
ages en route to or in the olfactory bulb (OB).
Genome-wide analyses reveal that the majority of
genes downregulated in the Brg1 null SEZ and OB
contain Pax6 binding sites and are also downregu-
lated in Pax6 null SEZ and OB. Downstream of the
Pax6-BAF complex, we find that Sox11, Nfib, and
Pou3f4 form a transcriptional cross-regulatory
network that drives neurogenesis and can convert
postnatal glia into neurons. Taken together, ele-
ments of our work identify a tripartite effectorCenetwork activated by Pax6-BAF that programs
neuronal fate.
INTRODUCTION
Cell fate specification includes multiple steps in restricting pro-
genitor potential and directing the expression of genes that elicit
a lineage-specific program. According to the ‘‘master regulator
concept,’’ a single gene expressed in competent tissue is
capable of inducing the expression of the entire lineage-specific
transcriptional cascade, resulting in final and complete fate
commitment (Baker, 2001). However, the molecular mecha-
nisms by which these master regulators work are not clear. It is
unknown for most lineages if master regulators directly control
multiple genes executing lineage decision and differentiation of
cells further along the lineage or only control a few downstream
effector genes, as, e.g., proposed by the concept of terminal
selector genes (Hobert, 2011). The transcription factor Pax5, a
master regulator of B cell fate in the hematopoietic system,
promotes B cell differentiation and maintenance of B cell fate
(Medvedovic et al., 2011), exploiting the epigenetic machinery
to either shut down expression of genes of other lineages or acti-
vate genes of the B cell lineage (McManus et al., 2011). Thus,
Pax5 directly regulates many effector genes and stabilizes thell Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc. 403
Figure 1. Loss of Brg1 Function Renders Neuronal Progenitors into Glial Cells
(A) Western blot depicting the direct interaction of Pax6 and BAF complex.
(B–E) Micrographs depicting coexpression of Pax6 and Brg1 in DCX+ neuroblasts (blue arrow in D and E). (D) and (E) are magnifications of area boxed in (B) and
(C), respectively.
(legend continued on next page)
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regulators have relatively weak activation capacity themselves
(e.g., Hnf3b and Sry transcription factors) but have the capacity
to open chromatin-enabling binding and transactivation by other
transcription factors executing the lineage decision (Zaret and
Carroll, 2011).
These mechanisms remain largely open for neural fate deci-
sions. Key transcriptional regulators of neurogenic fate have
been identified in the developing and adult brain, such as
Pax6, Neurog2, Ascl1, SoxC, and Dlx2 (Bergsland et al., 2011;
Hack et al., 2005; Heins et al., 2002; Mu et al., 2012; Nieto
et al., 2001; Petryniak et al., 2007). However, it is still largely
unknown how these transcription factors act at the molecular
level to direct neuronal fate decisions. While ChIP experiments
and mouse mutant analysis for Pax6, Ascl1, and SoxC (Sox4
and Sox11) revealed binding and regulation of genes involved
in proliferation as well as neurogenesis (Asami et al., 2011;
Bergsland et al., 2011; Castro et al., 2011), the key molecular tar-
gets allowing these factors to orchestrate neurogenesis and
neuronal reprogramming have not yet been identified.
In direct reprogramming, it appears that the number of factors
necessary for fate conversion is inversely correlated to the dis-
tance of their lineage relation. If cells share a common lineage,
such as glia with neurons, they can be converted with one factor
(Davis et al., 1987; Heinrich et al., 2010; Heins et al., 2002), while
turningmore distinctly related cells, such as fibroblasts, into neu-
rons requires several factors (Vierbuchen et al., 2010; Yoo et al.,
2011). This may reflect the state of the chromatin in the initial cell
and reinforces the importance of transcription factors in chro-
matin restructuring and opening of new binding sites for fate
conversion (Siersbæk et al., 2011; Zaret and Carroll, 2011).
However, virtually nothing is known about the interaction of
key neurogenic factors with the chromatin-modifying machinery.
Several chromatin remodeling factors have been found to be
important during neural development, including members of
the Brm-associated factor (BAF), CHD, and ISWI complexes
(Engelen et al., 2011; Ho et al., 2009; Yip et al., 2012). For
example, conditional deletion of the ATPase subunits Snf2l or
Brg1 of the ISWI or BAF chromatin remodeling complexes
reduced neural stem cell (NSC) proliferation and self-renewal in
the developing forebrain (Lessard et al., 2007; Matsumoto
et al., 2006; Yip et al., 2012). These chromatin-remodeling com-
plexes appear necessary to regulate expression of proprolifera-
tive genes, such as Foxg1 (Yip et al., 2012), and Notch and Sonic
Hedgehog pathway genes (Lessard et al., 2007). Interestingly,
whether the BAF complex regulates proliferation or neuronal dif-
ferentiation (Wu et al., 2007) depends on its subunit composition
(Ho et al., 2009). In mammals, BAF complexes contain the
ATPase subunits Brg1 or Brahma, which are mutually exclusive
and essential for remodeling activity, and comprise up to 12(F and G) Representative micrographs of the olfactory bulbs of Brg1 cKO (G) and
(H–K) Micrographs depicting the immunoreactivity of recombined cells for DCX a
(L and M) Micrographs depicting the diverse morphology of NG2+ cells generate
(N) Histogram depicting the total number of NG2+ cells in OB 28 days after rec
***p% 0.005.
(O) Pie charts illustrating the identity of recombined cells in the OB 28 days after
Scale bars: 100 mm in (B), (C), (F), and (G); 50 mm in (L)–(M); 20 mm in (D), (E), and
migratory stream; SEZ, subependymal zone; St, striatum; lv, lateral ventricle; GL
deep granule cell layer; sGCL, superficial granule cell layer. See also Figures S1
CeBrg1/BAF subunits. Depending on specific BAF complex sub-
units, this complex is involved in NSC maintenance or neuronal
differentiation (Ho et al., 2009; Singhal et al., 2010). However, it
is not known how these specific complexes are targeted to
and regulate the respective and distinct targets and to which
extent they may interact with specific transcription factors.
To shed light on the molecular mechanisms underlying the
function of key neurogenicmaster regulators in fate specification
and conversion, we chose to search for Pax6 interactors. Pax6 is
not only amaster regulator in eye development (Baker, 2001) and
in neurogenesis (Brill et al., 2008; Go¨tz et al., 1998; Hack et al.,
2005; Heins et al., 2002; Stoykova and Gruss, 1994), but it is
also sufficient to reprogram glia into neurons (Berninger et al.,
2007; Buffo et al., 2005; Heins et al., 2002). Understanding
how Pax6 exerts its neurogenic function is therefore of crucial
interest to reveal the basic principles of endogenous and
enforced neurogenesis.
RESULTS
Transcription Factor Pax6 Interacts with BAFChromatin
Remodeling Complex in Neurogenic Progenitors
In order to understand the mechanisms underlying Pax6-medi-
ated neurogenesis, we purified Pax6-containing complexes
from NSCs expressing Pax6 (Figure S1A available online) and
used mass spectrometry to examine their composition. Pax6
complexes were purified by either Pax6 antibody (Pax6-IP,
Figure 1A) or FLAG antibody from NSCs stably expressing
FLAG-tagged Pax6 (FLAG-Pax6-IP, Figure S1B). In either case,
multiple subunits of the BAF complex were present in the Pax6
samples. The interaction of Pax6 with the BAF complex was
confirmed by western blot (WB) detection of the BAF complex
in Pax6 immunoprecipitations (Figure 1A). Thus, Pax6 physically
interacts with Brg1-containing BAF chromatin remodeling com-
plexes in NSCs. To examine this in the brain, we prepared
nuclear extracts from the core of the adult mouse olfactory
bulb (OB), which is enriched in Pax6+ neuroblasts (Hack et al.,
2005; Brill et al., 2008). Immunoprecipitation with Pax6 antibody
followed by WB for Brg1 (Figure 1A) confirmed the interaction of
Brg1-containing complexes with Pax6 in the OB.
Toexaminecolocalization ofPax6andBrg1at thecellular level,
we performed immunostaining for Brg1 in the adult brain, which
showed a broad expression of Brg1 in neurons and astrocytes
throughout the brain, while surprisingly weak immunoreactivity
for Brg1was detectable inwhitematter (WM)wheremostly oligo-
dendrocytes and their precursors reside (Figure 1B; Figure S1C).
In the subependymal zone (SEZ), the region of the adult brain
generating OB interneurons in Pax6-dependent manner (Hack
et al., 2005; Brill et al., 2008), Brg1-immunoreactive nuclei were
detected in GFAP+ astrocytes and NSCs as well as in Ascl1+corresponding control (F) 28 days after recombination.
nd NG2. (J) and (K) are magnifications of area boxed in (H) and (I), respectively.
d from the Brg1-deficient neural progenitors.
ombination. Data are shown as mean ± SEM and n(animals) R 5. *p % 0.05;
recombination. Data are shown as mean and n(animals)R 5.
(H)–(K). Abbreviations: ctx, cerebral cortex; cc, corpus callosum; RMS, rostral
, glomerular layer; GCL, granule cell layer; EPl, external plexiform layer; dGCL,
and S2.
ll Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc. 405
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neuroblasts (Figures S1D and S1E and data not shown). Impor-
tantly, we also observed the expression of BAF53a and BAF45a
(Figures S1F and S1G; but not BAF45b and BAF53b, Figures
S1HandS1I), subunits characterizing the neural-progenitor-spe-
cific BAF complexes (Lessard et al., 2007). Conversely, Pax6
immunoreactivity is largely restricted to neuroblasts in the SEZ
and rostral migratory stream (RMS), where it colocalizes with
Brg1 (Figures 1D and 1E). Together with the immunoprecipitation
experiments, these data suggest that Pax6 interacts with the
neural-progenitor-specific, Brg1-containing BAF chromatin re-
modeling complex in neuroblasts in vivo.
Loss of Brg1 in Adult NSCs Converts OB Neurogenesis
into Gliogenesis
To test the functional relevance of the observed Pax6-BAF inter-
action,we ablatedBrg1 in theBrg1flmouse line (Indra et al., 2005;
Matsumoto et al., 2006) by tamoxifen (TM) inducible Cre-based
excision in GlastCreERT2 mice, mediating genomic recombination
in astrocytes and NSCs (Mori et al., 2006; Ninkovic et al., 2007).
These mice were also crossed with the CAG-CAT-GFP reporter
line (Nakamura et al., 2006), allowing visualization of the recom-
bined cells. By 9 days post TM administration (9 dpt), 95% of
reporter+ cells in GlastCreERT2/Brg1fl/fl mice (further referred as
Brg1 cKO) were no longer Brg1-immunopositive, while virtually
all reporter+ cells were Brg1+ in GlastCreERT2/Brg1fl/+ or
GlastCreERT2/Brg1+/+ mice (further referred as Brg1 controls)
(Figures S2A–S2C).
While no altered neurogenesis was detectable in the SEZ,
RMS, or OB of Brg1 cKO mice 9 dpt (Figure S2D), 28 dpt the
number of recombined cells was significantly reduced in the
OB (Figures 1F and 1G) compared to Brg1 controls. As this
may be due to cell death, we examined activated caspase3, an
indicator of programmed cell death. Indeed, the number of acti-
vated caspase3+ cells was significantly increased in the OB and
RMS, but not in the SEZ, of Brg1 cKOmice compared to controls
(Figure S2E and data not shown). This suggests that cell death is
initiated at later stages in the neuroblasts when they migrate
along the RMS. We also observed an increase in GFP+ cells
located just beside the RMS (Figure S2F–S2H) with a
morphology reminiscent of oligodendrocyte progenitor cells
(OPCs). Staining for the transcription factor Olig2 (data not
shown) and proteoglycan NG2 labeling of OPCs (Dimou et al.,
2008) confirmed the strikingly higher number of GFP+ OPCs in
Brg1 cKO (Figures 1I and 1K–1O; 2,0003 increase) while virtually
no GFP+ OPCs were detectable in the OB of control animals
(Figures 1H and 1J). Notably, GFP+ OPCs were present only at
the end of the RMS, in the core of theOB, and in the deep granule
cell layer (GCL) (Figure 1N). The newly generated OPCs dis-
played a variety of morphologies with different levels of cellular
complexity (Figures 1K–1M) indicative of different stages in the
oligodendrocyte lineage. However, even 2 months after TM, no
GFP+ cells had matured into oligodendrocytes immunoreactive
for GST-p. Interestingly, other glial cells, like GFAP+ astrocytes
(Figure 1O and Figures S2J–S2K0) and marker-negative cells
(Figures S2L and S2L0—cells were immunoprobed for more
than 20 antigens indicative of astroglial, neuronal, oligodendrog-
lial, endothelial, and microglial lineage as well as fibroblasts; see
Experimental Procedures), were also increased in Brg1 cKOOB,406 Cell Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc.reflecting a broader conversion toward gliogenesis and some
cells failing to adopt any coherent cell identity after loss of
Brg1 (Figure 1O and Figure S2L). Conversely, cells of the
neuronal lineage were strongly reduced in number to less than
one-third (Figure 1O and Figure S2M), with the only exception
being neurons in the superficial GCL (Figure S2M), indicating
that this neuronal sublineage is selectively spared by Brg1 deple-
tion and accounts for almost half of the remaining neurons. Ergo,
inducible, cell-specific deletion of Brg1 in vivo converts adult OB
neurogenesis to gliogenesis starting in the RMSand is accompa-
nied by increased cell death.
GlastCreERT2-mediated recombination is not restricted to the
SEZ and RMS, the origin of adult OB neurogenesis, but also
depletes Brg1 in astrocytes throughout the brain. Therefore, it
is possible that some astrocytes in the OB and RMSmay be con-
verted to OPCs.While no GFP+OPCswere detected outside the
OB (data not shown), it remains possible that specifically astro-
cytes in the OB would be more easily converted to OPCs. To
examine the fate of cells originating in the SEZ directly, we
injected dsRed-expressing MLV-based retroviral vectors 9 dpt
into the SEZ of GlastCreERT2//Brg1fl/fl//CAT-CAG-GFP animals
in order to label Brg1 cKO progenitors (dsRed+/GFP+) and their
WT cellular counterparts (not recombined and hence GFP, but
dsRed+) already in the SEZ (Figures S3A and S3B). When we
analyzed the identity of labeled cells in the OB 7 days later,
most of the dsRed+, GFP control cells (more than 90%) were
DCX+ neuroblasts, as is normally the case (Figure S3B). How-
ever, only a minority (40%) of the Brg1-deficient cells (dsRed+,
GFP+) originating in the SEZ had acquired a neuroblast identity
(Figure S3B) and a significant proportion expressed Olig2 (Fig-
ure S3B). As this proportion was similar to the GFP+, dsRed
(38% for DCX and 36% for Olig2), we conclude that there is no
major additional source of cells contributing to the OPCs in the
OB of Brg1 cKOmice. Thus, most cells from the SEZ fail to com-
plete their neurogenic fate upon Brg1 deletion and convert to
gliogenesis.
Viral vector injection causes an injury in the SEZ, which may
affect the lineage progression. To address this possibility and
verify the above findings, we deleted Brg1 with the Nestin-
CreERT2 line (Lagace et al., 2007) mediating recombination
exclusively in nestin+ cells of the SEZ, but not in the nestin-
negative parenchymal glia. Consistent with our findings with
the GlastCreERT2 mice shown above, mice that lack Brg1 in
nestin+ cells and their progeny had significantly fewer GFP+
cells reaching the OB and acquiring a neuronal identity
compared to control mice 30 dpt (Figures S3C and S3D). Similar
to the GlastCreERT2-mediated deletion of Brg1, these cells
expressed Olig2. Taken together, multiple independent experi-
mental approaches confirm that Brg1 is an essential component
of SEZ-derived neurogenesis, and that the absence of Brg1
causes the conversion of neuroblasts in the RMS and OB to
the glial lineages.
Niche-Dependent Gliogenesis Elicited by Loss of Brg1
Because our fate mapping experiments demonstrated that the
reporter+ glia in the OB originate from the SEZ, we examined
cells in the SEZ of Brg1 cKO mice. However, even 28 dpt
(17 days after loss of Brg1 protein), numbers of DCX+
neuroblasts among the recombined (GFP+) cells in the SEZ
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BAF Complex in Fate Decisiondid not significantly differ between Brg1 cKO and control mice
(Figures S3E and S3F), suggesting that conversion to
gliogenesis occurs only when neuronal cells exit the SEZ.
This strikingly late fate conversion may be due to a powerful
role of the niche environment or other intrinsic mechanisms suf-
ficient to stabilize neuronal fate (Beckervordersandforth et al.,
2010; Colak et al., 2008; Lim et al., 2006). To distinguish
between these two possibilities, we isolated progenitors from
the SEZ of Brg1 cKO or control mice 9 dpt and cultured
them in a primary SEZ culture system maintaining neurogenesis
(Costa et al., 2011). Consistent with the in vivo analysis of
neurogenesis in the SEZ (Figure S3E), we did not observe
any difference in cell composition of the SEZ in Brg1 cKO
and respective controls after isolating cells 7 dpt and analyzing
them 4 hr after plating (Figure S3G). However, cells lacking
Brg1 were not able to proceed further along the neurogenic
lineage also after 7 days in vitro, because only 9% of them
were DCX+ neuroblasts in contrast to 60% of control cells (Fig-
ures 2A–2D). Intriguingly, Brg1-deficient cells now differentiated
in CD24+ ependyma-like cells in addition to NG2+ OPCs (Fig-
ures 2C and 2D and Figure S3H).
These observations prompted us to ask if ependymal cells are
generated also in the SEZ in vivo after Brg1 deletion. To address
this question, we used the recently developed Split-Cre technol-
ogy that specifically mediates recombination in SEZ NSCs using
two halves of Cre driven by GFAP and P2 prominin promoters
simultaneously active in NSCs (Beckervordersandforth et al.,
2010). Stereotactic injection of two lentiviruses encoding each
half of Cre under the respective GFAP or P2 promoter into
Brg1fl/fl//CAG-CAT-GFP or Brg1fl/+//CAG-CAT-GFP mice allows
us to selectively delete Brg1 in NSCs and follow their progeny by
the GFP reporter. The majority of GFP+ cells were neuroblasts
60 days after virus injection into control mice with very few
ependymal cells labeled (Figure S3I–S3K), while the progeny of
Brg1-deficient NSCs contained 30% ependymal cells (Fig-
ure S3I–S3K). Taken together, these data imply that the local
niche not only influences the selection of glial fate subtype
after Brg1 deletion, but also contributes to maintenance of
some cells as neuroblasts even in the absence of Brg1, because
virtually all cells convert to gliogenesis outside this neurogenic
niche in vitro.
Mode of Fate Conversion Determined by Continuous
Single-Cell Live Imaging In Vitro
Because Brg1-deficient cells in vitro largely convert into the
same cell types as in vivo, we used single-cell continuous live
imaging for 7 days in vitro followed by postimaging immuno-
staining to discriminate whether the conversion of Brg1 cKO
cells from neurogenesis to gliogenesis occurs by selective cell
death, selective proliferation, or a true fate conversion (Movie
S1, Movie S2, and Movie S3; Figures 2E–2I). In agreement with
the population-based analysis, 93% of lineage trees in controls
contained only neuronal cells, and only a small fraction of trees,
derived from the NSCs, had generated both neurons and glia
(Figures 2E and 2G). In contrast, when we observed Brg1 cKO
cells, most of the trees contained either NG2 glia or epen-
dyma-like cells, but only a minority had generated neurons
only (Figure 2F). Interestingly, cells giving rise to ependyma-
like cells were the only lineage that initially performed a seriesCeof fast symmetric proliferative divisions (Figure 2F). Other than
this, cell cycle length did not differ between control and Brg1
cKO cells (Figure 2G), nor could we observe any difference in re-
gard to cell death that was rather rare in both control and Brg1
cKO cells (Figures 2E, 2F, and 2H). Thus, Brg1 cKO cells convert
to glial lineages by fate change rather than selective cell death or
proliferation. Because most of the control and Brg1 cKO cells at
the start of these cultures are neuroblasts (63% ± 4%, Fig-
ure S2D), and no selective cell death of Brg1 cKO cells was
observed, these experiments demonstrate that many Brg1
cKO neuroblasts directly convert to glial lineages.
Loss of Brg1 Leads to Downregulation of Pax6 Targets
in Adult SEZ and OB
Given the surprisingly specific defects in neurogenesis after
deletion of Brg1, we used genome-wide expression analysis to
identify genes involved in this phenotype. We isolated the SEZ
and core of the OB (containing neuroblasts entering the OB)
from Brg1 cKO and control mice 10 dpt, just 1 day after loss of
Brg1 protein. Genome-wide expression profiling (GST 1.1 gene
array, Affymetrix, USA) revealed 244 significantly regulated
genes (change in the expression level >1.2 or <0.8 and p <
0.05) in the OB (Table S1 available online) and 136 genes in the
SEZ (Table S2 and Figure S4A), and qPCR on independent
samples confirmed the reliability of this analysis (Figure 3A).
Importantly, most of the significant gene ontology (GO) terms
were related to neurogenesis, synaptic transmission, axonogen-
esis, and cell migration, consistent with defective neurogenesis
(Figures S4B and S4C). The other major terms were related to
DNA and RNA metabolism and cell replication and cell cycle,
suggestive of defects in cell cycle regulation in Brg1 cKO SEZ
and OB and possibly linked to the very specific cell division
pattern of ependymal cell generation we observed using live
imaging (Figure 2F). Interestingly, 64% of the downregulated
genes in SEZ (Figure S4E) are expressed in NSCs and their
progeny, as identified in our previous transcriptome analysis
(Beckervordersandforth et al., 2010 and Figures S4D–S4F).
Most intriguingly, 89.79% of the downregulated genes had
predicted Pax6 binding sites, a significant enrichment in regard
to the expected frequency (63% expected, Genomatix Matins-
pector) (Figure 3B). This suggests that most genes downregu-
lated in Brg1 cKO may be regulated by Pax6 in conjunction
with a Brg1-containing BAF complex.
Deletion of Pax6 Phenocopies Brg1 Deletion and
Converts Adult SEZ Neurogenesis to Gliogenesis
In order to test the above suggestion directly in vivo, we
crossed the floxed Pax6 mice (Ashery-Padan et al., 2000) with
GlastCreERT2 mice to delete Pax6 in the same manner as we
deleted Brg1. While Pax6 protein was more stable than Brg1
and disappeared only 21 dpt (Figures S5A–S5C), the phenotype
emerging thereafter was remarkably similar to the phenotype
observed in Brg1 cKO mice. As in the Brg1 cKO mice, we
observed fewer numbers of GFP+ cells reaching the OB in the
Pax6 cKO mice compared to controls (Figures 3C and 3D),
and most of them no longer differentiated along the neuronal
lineage (DCX+/ NeuN+ 45%, compared to 82% in controls, Fig-
ures 3E and 3G–3H), but rather converted to glial identities
(Figures 3F and 3G–3H) in ratios similar to the Brg1 cKO cellsll Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc. 407
Figure 2. Loss of Brg1 Results in Full Conversion of Neural Progenitors to Gliogenesis In Vitro
(A–C) Micrographs depicting the immunoreactivity of GFP+ progeny of NSCs derived from either Brg1 cKO or age matched controls (10 days after TM induction)
after 7 days in vitro.
(D) Pie charts depicting the composition of the NSC progeny following Brg1 depletion or controls after 7 days in vitro. Data are shown as mean and n(animals
analyzed)R 7.
(E and F) Representative trees illustrating the predominant behavior of the Brg1 KO or control neural progenitors in vitro.
(G) Box-chart showing the cell cycle length (the time between two divisions) of control and Brg1 cKO progenitors.
(H) Histogram depicting the proportion of clones containing at least one dead cell. Data are shown as mean (three experiments) ± SEM.
Scale bars: 100 mm in (A), (B), and (C). See also Figure S3, Movie S1, Movie S2, and Movie S3.
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Figure 3. Brg1 Deletion Results in Downregulation of Pax6 Target Genes and Is Phenocopied by Pax6 Deletion
(A) Histogram depicting the comparison of a specific gene set misregulated after Brg1 deletion andmeasured bymicroarray and qPCR on independent samples.
Data are shown as mean and n(animals)R 3.
(B) Venn diagram depicting predicted Pax6 binding sites in the promoters of genes deregulated in Brg1 KO.
(C and D) Representative micrographs of the OB of controls (C) and Pax6 cKO (D) 60 days after recombination.
(E and F) Micrographs depicting the immunoreactivity of recombined, GFP+ cells.
(G) Histograms depicting the total number of NG2+ cells in OB 60 days after recombination. Data are shown as mean ± SEM and n(animals) R 7. *p% 0.05;
***p% 0.005.
(H) Pie charts illustrating the identity of recombined cells in the 60 days after recombination. Data are shown as mean and n(animals)R 3.
Scale bars: 100 mm in (C) and (D); 20 mm in (E) and (F). For abbreviations see Figure 1. See also Figure S4.
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with Brg1-containing BAF complex in vitro and in vivo, deletion
of either of these proteins results in the same phenotype with se-
vere defects in OB neurogenesis, implying a key role of this tran-
scriptional complex in regulating neurogenesis.CePax6 and Catalytically Active Brg1 Are Both Essential
for Forced Neurogenesis
The above findings prompted us to examine to which extent
Pax6-induced neurogenesis would also require the presence
of Brg1. Toward this end, we prepared neurosphere cells fromll Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc. 409
Figure 4. Pax6 Requires Catalytically Active Brg1 for Its Neurogenic Function
(A–C) Micrographs depicting immunoreactivity for neuronal marker DCX of Brg1 cKO cells (green) derived from Brg1fl/fl neurospheres after overexpression of
control vector (A), Pax6 (B), and Ngn2 (C) 7 days after transduction.
(D and E) Histograms depicting the proportion of neurons generated from neurosphere cells 7 days after expression of Pax6, Ngn2, Brg1, and Brg1KS (ATPase
deficient form).
(legend continued on next page)
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with viral vectors encoding Cre to obtain Brg1-deficient cells
(Figures 4A–4D). Two days after transduction, Brg1 protein
was virtually absent from the Cre-transduced cells, while 95%
of control virus transduced cells were still Brg1+ (data not
shown). Importantly, Cre-transduced, Brg1 cKO cells largely
failed to generate any DCX+ neurons (Figures 4B and 4D),
in agreement with the above observed results that Brg1 is
necessary for endogenous neurogenesis. Moreover, Pax6 over-
expression did not induce neurogenesis in Brg1 cKO cells
(cotransduced with CreIRESGFP virus), in contrast to the control
situation where Pax6 transduction induced about 70%
DCX+ neurons (Figure 4D). Importantly, the full-length form of
Brg1, but not the ATPase deficient form (Brg1KS), restored
both endogenous and Pax6-induced neurogenesis (Figure 4E),
demonstrating that Brg1 needs to be catalytically active to
mediate neurogenesis. The requirement of Brg1 for neuro-
genesis is rather specific for Pax6, as transduction with the
neurogenic factor Ngn2 resulted in very efficient induction of
neurogenesis to over 90% even in the absence of Brg1 (Figures
4C and 4D). Thus, Pax6 and Brg1 are not only required for
endogenous OB neurogenesis, but also, neurogenesis forced
by Pax6 overexpression requires the presence of catalytically
active Brg1 and hence chromatin remodeling activity.
Identification of a Neurogenic Transcriptional Network
Downstream of Pax6 and Brg1
Given the similarity of the phenotypes after deletion of either
Pax6 or Brg1 in adult NSCs of the SEZ and functional interaction
in forced neurogenesis, we next asked to which extent this is
also reflected at the transcriptional level. First, we examined
randomly selected genes, found to be downregulated in the
core of the OB or the SEZ of Brg1 cKO mice, in the OB and
SEZ of Pax6 cKO mice. Consistent with the similarity at the
phenotypic level, 90% of these genes downregulated after loss
of Brg1 were also downregulated after loss of Pax6 (Figure 4F
and data not shown), in agreement with the observation that
the majority of these genes possess Pax6-binding sites. This
provided us with an opportunity to search for genes implement-
ing neurogenesis. We therefore searched for transcriptional
regulators downregulated upon Brg1 depletion with a common
regulatory motif including Pax6. This was the case for 11
of the 17 downregulated transcription factors (Figure 4G;
FrameWorker, Genomatix, Germany) and only for 4 of these a
specific consensus DNA binding sequence was described
(Sox11, Sox4, Pou3f4, and Nfib). Indeed, all these are expressed
in the SEZ and RMS (Figures S5G–S5J) and their expression is
downregulated in both Brg1 cKO and Pax6 cKO OB (Figure 4H).(F) Histogram depicting downregulation of genes following Brg1 or Pax6 deletion
(G) Venn diagram depicting transcription factors downregulated in Brg1 cKO and
(H) Histogram showing the downregulation of Pou3f4, Sox11, and Nfib in the OB
(I) Histogram depicting the Pax6-mediated induction of the expression of Pou3f4
(J and K) Micrographs depicting deletion of Brg1 in neurosphere cells 36 hr after
(L) Histogram depicting the Pax6-mediated induction of the expression of Pou3f
nucleofection.
(M) Histogram depicting the relative expression of Pou3f4, Sox11, and Nfib in th
Scale bars: 100 mm in (A)–(C), (J), and (K). Data in (D), (E), (H), (I), and (L) are sh
**p% 0.01; ***p% 0.005.
CeThis reduction was relevant at protein levels; for example, Nfib
was present in virtually all neuroblasts in the RMS, but upon
loss of Pax6 (GFP+ cells in Pax6 cKO 60 dpt) only 17%of recom-
bined, GFP+ neuroblasts expressed Nfib (Figure S5K–S5M).
Pax6 was also sufficient to induce Sox11 and Pou3f2/4
expression within 24 hrs in neurosphere-derived cells (Figure 4I)
in a Brg1-dependent manner (Figures 4J–4L). Interestingly, the
expression of Sox11, Nfib, and Pou3f4 was highest in neuro-
blasts expressing the highest levels of Pax6 (Figure 4M). Thus,
the regulation and expression of these transcription factors is
consistent with a role downstream of the Pax6-Brg1 complex
in neuroblasts.
Most importantly, these downstream transcription factors
were also predicted to cross-regulate each other, thus poten-
tially forming a self-sustaining cross-regulatory network critical
for neurogenic fate maintenance in the adult brain. To test this
we first examined if each of these factors could indeed induce/
increase expression of the respective others. Indeed, Sox11
overexpression in adult neurosphere-derived cells increased
mRNA for Nfib, and Pou3f4 and Pou3f2 overexpression
increased Sox11, Pou3f4, and Nfib, but none of these increased
Pax6 mRNA levels (Figure 4I), consistent with the concept of a
downstream cross-regulatory transcriptional network. Chro-
matin-immunoprecipitation (ChIP) followed by quantitative
PCR (qPCR) further demonstrated not only Pax6 binding in the
promoter regions of Sox11, Nfib, and Pou3f4, but also binding
of the respective other members of this network (Figures
5A–5C). Moreover, ChIP-seq experiments identified Brg1 bind-
ing in the promoters of Sox11, Pou3f4, and Nfib (Figure 5D) in
NSCs isolated from E10.5 embryos. These data further support
the concept that Pax6 binds in close interaction with a Brg1-con-
taining BAF complex in the promoter regions of each member of
this cross-regulatory network.
As a further test for Sox11, Pou3f4, and Nfib acting as a cross-
regulatory neurogenic network initiated by Pax6 interacting with
Brg1-containing chromatin remodeling complexes, we exam-
ined to which extent neuronal specification and differentiation
genes downregulated after Brg1 depletion contain a regulatory
motif composed of SoxC, Pou3f4, and Nfib binding sites. Inter-
estingly, a total of 65% of genes downregulated in the Brg1
cKO have binding sites for Nfib, Sox11, and Pou3f4 with
conserved distance and orientation (25%) or a regulatorymodule
containing at least two of them (40%, Figure S6A). Sox11, Nfib,
and Pou3f4 themselves are among these regulatory-module-
containing genes (Figure S6A), further supporting the validity of
this motif analysis because these bindings have been confirmed
by ChIP-qPCR (Figures 5A–5C). Other than these, however, the
set of SoxC/Pou3f4/Nfib binding genes does not comprise. Gene expression in the mutant and WT is normalized to the GAPDH.
harboring Pax6 binding sites in their promoters.
and SEZ following Brg1 and Pax6 deletion.
and Sox11 in neurosphere cells 24 hr after transfection.
nucleofection of corresponding plasmid.
4, Sox11, and Nfib in control or Brg1 cKO neurosphere cells 24 hr after Pax6
e FACS-purified populations enriched in NSCs and their progeny.
own as mean ± SEM and n(animals) R 3 and in (M) as mean n(animals) R 3.
ll Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc. 411
Figure 5. Identification of the Core Regulatory Network Downstream of Pax6-Brg1 Complex Necessary for Neurogenesis
(A–C) Histograms depicting ChIP signals of Pax6, Pou3f4, and Nfib. x axis indicates the position in the promoters in kb starting from the TSS and the underlined
position contained the predicted Pax6 binding site. Data are shown as mean ± SEM and n(experiments)R 5.
(D) Genome browser snapshot containing the Brg1 ChIP-seq signals.
(E) Scheme depicting cross-regulatory loop regulated by Pax6-Brg1 complex.
See also Figures S5 and S6, Table S1, and Table S2.
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effector molecules involved in neuronal migration and differenti-
ation or interaction to extracellular matrix. These data therefore
suggest that Sox11, Pou3f4, and Nfib act as a cross-regulatory
transcriptional network downstream of Pax6/Brg1-containing
complexes regulating a multitude of effector genes involved in
neuronal differentiation and migration, thereby implementing
and stabilizing the initial fate (Figure 5E).
The Function of BAF-Pax6 Complex Is Necessary to
Maintain the Core Network in the Neuroblasts
The above concept suggests an effector network stabilizing
neuronal fate in neuroblasts or late stages of TAPs, when Pax6
and the downstream effectors are detectable by immunostain-
ing. Moreover, upon deletion of either Brg1 or Pax6, conversion
to gliogenesis occurred in the RMS and core of the OB, i.e.,
regions mostly composed of neuroblasts. However, we had412 Cell Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc.also observed ependymal cells in the SEZ emerging after Brg1
deletion in NSCs, consistent with a possible direct conversion
of NSCs into this fate upon Brg1 deletion. To further test fate
conversion after Brg1 deletion at later stages in the lineage, we
used MLV-based retroviruses to transduce only fast dividing
TAPs and neuroblasts with Cre as previously shown (Colak
et al., 2008). Transduced cells were analyzed 21 days after
stereotactic virus injection, allowing sufficient time for the trans-
duced progenitors to differentiate in the OB. While 90% of con-
trol-virus-infected cells had arrived in the OB and differentiated
into DCX or NeuN+ neurons with the typical morphology of
granule cells (Figure 6A, 6B, and 6E–6G and Figure S6B), cells
transduced with the Cre-containing virus were mostly located
outside theOB next to the RMS in the cortical WMor the striatum
(Figure 6C, 6E, and 6F). Accordingly, most Cre-transduced cells
were Olig2+ or NG2+ glia located outside the SEZ and the RMS
(Figure 6F, 6H, and 6I) and only a few, mostly located in the
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described above, expressed DCX (Figure 6F and data not
shown). Interestingly, Olig2 expression already started in cells
within the RMS (Figure 6H and 6I), suggesting that the fate con-
version upon Brg1 deletion starts in the RMS in agreement with
transcriptional changes in neuroblast genes (Figure 3A and
Figure S4). Interestingly, a significant (40%) proportion of the
Cre-transduced Brg1 cKO cells remained in the SEZ even
21 days after the transduction. These were nonproliferative
(Ki67, data not shown) astrocytes (GFAP+) or CD24+ ependy-
mal cells at the ventricular lumen (Figure 6K–6M). Importantly,
the latter were never observed among control transduced cells
(Figure 6M), indicating that Brg1 deletion in fast proliferating cells
integrating the MLV virus results in conversion to ependymal
cells in the SEZ, i.e., the reverse of ependymal cell-neuroblast
conversion after stroke injury (Carle´n et al., 2009). Taken
together, these experiments indicate that the Pax6-BAF com-
plex is required at later stages in the NSC lineage for neuroblast
fate maintenance, and its absence in these progenitors results in
conversion to the glial lineage as they fail to upregulate the cross-
regulatory effector network.
A Minimal Neurogenic Network Is Sufficient for Forced
Neurogenesis and Is Independent of Brg1
If Sox11, Nfib, and Pou3f4 can indeed function as a neurogenic
effector network as suggested by the above loss-of-function
experiments, these factors should also be sufficient to replace
Pax6 in forced neurogenesis in gain-of-function experiments
and act independent of Brg1, as expected for factors down-
stream of Pax6 and Brg1. We tested these predictions first
in adult neurosphere-derived cells, which already express Nfib
(Figures S7A and S7B), by introducing Sox11 and/or Pou3f4/
Pou3f2. Indeed, transfection with Sox11 increased the propor-
tion of transduced cells differentiating into neurons 6-fold (30%
DCX+ cells; 5% after transfection with control dsRed plasmid,
see also Haslinger et al., 2009; Mu et al., 2012), and Pou3f2 (as
well as Pou3f4, data not shown) was even more efficient with
an increase of about 12-fold more neurons (about 60% DCX+
cells; Figure 7A). Cotransfection of both Sox11 and Pou3f2
elicited neurogenesis in 75% of transduced cells, a proportion
not significantly different from the neurogenesis elicited by
Pax6 overexpression (Figure 4D). Moreover, Sox11 and Pou3f2
could still induce and enhance neurogenesis in the absence of
Brg1 after cotransduction of Cre into Brg1fl/fl neurosphere cells
(Figure 7A), in pronounced difference to Pax6 (Figure 4D). How-
ever, their function was critically dependent upon the presence
of the other members of the core regulatory network, because
genetic deletion of both Sox4 and Sox11 simultaneously or
knockdown of Pou3f2, Pou3f4, or Nfib (Figures S7C and S7D)
significantly reduced neurogenesis of neurosphere cells (Fig-
ure 7B). Likewise, deletion of Sox4 and Sox11 or knockdown
of Pou3f2 interferes with forced neurogenesis upon transduction
with Pax6, Sox11, or Pou3f2 (Figure 7C). These data further sub-
stantiate the concept of the cross-regulatory effector network,
because the other two members (endogenously expressed
Nfib or overexpressed Sox11 or Pou3f2) were not sufficient to
instruct neurogenesis in the absence of the third member. We
therefore conclude that the cross-regulatory transcriptional
network of SoxC, Pou3f, and Nfib is sufficient and necessaryCeto achieve equal levels of neurogenesis in the absence of Brg1,
consistent with its function downstream of this initiator complex.
Lastly, we examined to which extent this network may have a
broader relevance for reprogramming postnatal glial cells, which
would not generate neurons endogenously. Mixed glial cultures
from the postnatal cerebral cortex were cultured for 7 days and
infected with MLV-based viral vectors encoding for Pax6 or
Sox11 or Pou3f2 (because again, Nfib was found to be ex-
pressed in these cells endogenously), and we examined the
transduced cells 7 days later. As expected, virtually no DCX+
neurons were observed among control-virus-infected cells
(Figures 7D and 7F), while Pax6 was sufficient to instruct neuro-
genesis in 40% of all transduced cells (Figures 7E and 7F). Strik-
ingly, the combination of Sox11 and Pou3f2 was at least as effi-
cient in instructing the majority of glial cells toward neurogenesis
(Figure 7F), demonstrating that these factors are indeed able to
instruct neuronal differentiation also in glial cells.
DISCUSSION
Here, we demonstrate a role of chromatin remodeling in
conjunction with a specific neurogenic fate determinant, Pax6,
in neuronal fate commitment in the adult mouse brain in vivo.
We showed a physical interaction between Pax6 and a Brg1-
containing BAF complex and the functional requirement of either
factor for adult neurogenesis. If only one of these is missing, neu-
roblasts originating in the SEZ differentiate into glial cells in the
SEZ, en route to the OB, or even after completing the normal
migration and reaching the OB. Intriguingly, the conversion
occurs largely to NG2 glia in the OB and parenchymal regions
surrounding the RMS, while many ependymal cells are gener-
ated within the SEZ. This is of particular interest in light of signals
inhibiting oligodendrogliogenesis in this region (Colak et al.,
2008) and in regard to the finding that even fast proliferating cells
infected with the MLV-Cre virus can differentiate into ependymal
cells when not able to complete their neurogenic fate.
Importantly the loss of Brg1 affects with a striking specificity
Pax6-mediated neurogenesis. The specificity of this function is
particularly intriguing, as Brm, the other ATPase subunit of BAF
complexes, is expressed at even higher levels than Brg1 in neu-
roblasts (Figures S7E and S7F), but is obviously not able to
compensate for the loss of Brg1. Thus, not only individual BAF
subunits (Lessard et al., 2007; Yoo et al., 2009) convey specificity
to a BAF complex, but also the respective ATPase subunit. This
concept is further substantiated by specific defects upon Brg1
deletion in glial cell differentiation (Limpert et al., 2013; Weider
et al., 2012). Interestingly, Brg1 plays an important role in oligo-
dendrocyte differentiation in early postnatal development and
interacts with the transcription factor Olig2 in this context (Yu
et al., 2013), but its virtual absence in Olig2+ cells in the adult
forebrain suggests an intriguing difference between the molecu-
lar mechanisms acting at these different stages.
Indeed, the specific function of Pax6-Brg1/BAF complex in
neurogenesis also appears to be specific for the adult SEZ
lineage because the phenotypes caused by Brg1 or Pax6 dele-
tion in the developing telencephalon are rather different from
each other (Go¨tz et al., 1998; Heins et al., 2002; Lessard et al.,
2007; Matsumoto et al., 2006). Despite the coexpression of
Pax6 and Brg1 and neurogenic function of Pax6 in this regionll Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc. 413
(legend on next page)
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developmental stages does not affect neurogenic fate acquisi-
tion, but rather affects stem and progenitor cell proliferation
(Matsumoto et al., 2006). This raises the intriguing suggestion
that this interaction may have specific functions in adult neuro-
genesis that are not required in the developing brain. We there-
fore propose that mechanisms for neuronal fate stabilization are
particularly relevant in niches where gliogenesis is more preva-
lent. This concept is further substantiated by the relevance of
these factors in reprogramming glial cells into neurons.
Maintenance of Neurogenic Fate in the Adult Brain
by a Cross-Regulatory Neurogenic Network
One of the major differences between the developing and adult
brain is the prevalent neurogenesis in the former while gliogene-
sis largely dominates in the latter. Indeed, transplantation of
many NSCs into the adult brain parenchyma results in their con-
version to gliogenesis, whereas they readily generate neurons in
the developing brain (for review see Ninkovic and Go¨tz, 2013).
Thus, neuroblasts face particular challenges in the adult brain
to not convert to gliogenesis. Moreover, while the stem cells in
the developing telencephalon, the radial glial cells, express
high protein levels of neurogenic factors such as Pax6, adult
NSCs express these only at lower mRNA levels and need to
reach high protein levels when progressing further along the
lineage (Beckervordersandforth et al., 2010; Feng et al., 2013).
Indeed, our analysis shows that these two challenges can be
overcome by Pax6 interacting with a Brg1/BAF chromatin re-
modeling complex and activating a cross-regulatory neurogenic
transcriptional network required for stabilizing neurogenic fate in
the adult brain. First, we have shown that lack of either Pax6 or
Brg1 results in conversion of SEZ-derived cells toward different
glial cells, depending on their local environment as described
above. But even after isolation in vitro, SEZ cells lacking Brg1
or Pax6 can no longer complete a neurogenic fate, suggesting
that their intrinsic neurogenic factors inherited from NSCs are
not sufficient to prompt further progress along the neurogenic
lineage outside this niche. This demonstrates the critical role of
Pax6-Brg1/BAF complex activity in increasing the levels of
neurogenic fate determinants. Notably, this requires a catalyti-
cally active form of Brg1, demonstrating that chromatin remod-
eling is indeed critical for this step.
Here we discovered the molecular basis of Pax6/Brg1 com-
plex-mediated neurogenic fate maintenance by enhancing the
expression of neurogenic transcription factors forming a cross-
regulatory network. These transcription factors cross-regulate
each other and regulate neuronal effector genes. Importantly,
each member of this cross-regulatory network consisting of
SoxC, Pou3f, and Nfib factors is critical for neurogenesis. Previ-
ous work has already shown that SoxC factors are necessary for
neurogenesis (Mu et al., 2012), and their regulation depends alsoFigure 6. Brg1 Function Is Necessary in the TAPs and Neuroblasts
(A–D) Composite images of cells transducedwith control (A andB) and Cre-expres
animals. (B) and (D) are images of cells settled in the OB.
(E) Scheme depicting the position of control-virus- (green dots) and Cre-virus- (r
(F) Histogram depicting the distribution of transduced cells 21 days after injectio
(G–M) Micrographs and pies (M) depicting the identity of transduced cells after 2
Scale bars: 100 mm in (A)–(D) and 20 mm in (G)–(L). Abbreviations: cor, core of th
Ceon a chromatin remodeler interacting with Sox2 and Chd7 (Feng
et al., 2013). Interestingly, Chd7 is also downregulated upon
Pax6 or Brg1 deletion, further supporting the concept that
Pax6/BAF complex acts as an upstream regulator of these. In
addition we demonstrate here that also lowering the levels of
Pou3f or Nfib interferes with neurogenesis, demonstrating the
key role of each member of the cross-regulatory network to
achieve full neurogenesis. This cross-regulatory network then
activates genes mediating neuronal differentiation because a
large proportion of neuronal differentiation genes possess a
motif for either all three or at least two of these factors, such
as DCX, Tubb2b, CD24, and Prokr2.
Thus, our data suggest the following sequence of events (Fig-
ure S6C). Initiating neurogenic fate is mediated by factors such
as Pax6 that allow for altering the chromatin state via recruitment
of a chromatin remodeling complex, such as the BAF complex.
This Pax6-BAF complex then activates a cross-regulatory
transcriptional effector network sufficient to maintain the high
expression of genes involved in neuronal differentiation, thereby
executing the lineage decision. At this later stage, lineage
commitment can occur independent of Brg1 as demonstrated
by the expression of SoxC and Pou3f in cells lacking Brg1.
Notably, genes controlled by the cross-regulatory network
have a Pax6 binding site in addition to the Sox-Nfib-Pou3f regu-
latory motif, compatible with the idea that Pax6-Brg1 complex
might be important for making these loci accessible for high-
level expression that can then, once Nfib, Pou3f, and SoxC are
expressed at sufficiently high levels, be exerted independent of
the initial role of Pax6 and Brg1 (Figure S6C). Indeed, the deletion
of Brg1 in more committed TAPs and neuroblasts resulted in the
switch to the glia cells, adopting either NG2 glia or ependymal
glial fates. Consistent with this model, reduction of some mem-
bers of this cross-regulatory network results in defects of adult
SEZ neurogenesis as detailed above. Ultimately, this work has
unraveled a highly specific interaction of Pax6 with a chromatin
remodeling complex, consistent with the role of pioneer tran-
scription factors (Zaret and Carroll, 2011), and has further eluci-
dated the molecular logic of neurogenesis and neuronal fate
stabilization by illuminating a cross-regulatory effector network.EXPERIMENTAL PROCEDURES
Animal Experiments
All experimental procedures were performed in accordance with German and
European Union guidelines and were approved by our institutional animal care
committee and the government of upper Bavaria.
Viral Constructs Virus Production and Stereotactic Injections
A CAG-dsRed vector (Heinrich et al., 2010) was used for fate mapping
experiments, and Split-Cre constructs for the stem-cell-specific recombina-
tion (Beckervordersandforth et al., 2010) and viral particles were produced
as previously described (Beckervordersandforth et al., 2010; Hack et al.,sing virus (C andD) 21 days after injections of the virus in the SEZ of Brg1 floxed
ed dots) transduced cells 21 days after stereotactic injections.
n. Data are shown as mean (three animals) ± SEM.
1 days.
e OB; and see Figure 1.
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Figure 7. Cross-Regulatory Loop Genes Induce Neurogenesis from
Glia Cells Independent of Pax6-Brg1 Complex
(A and B) Histograms depicting the proportion of neurons generated after
forced expression (A) or loss of function (B) of cross-regulatory loop genes in
cells derived from neurospheres after 7 day in vitro.
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416 Cell Stem Cell 13, 403–418, October 3, 2013 ª2013 Elsevier Inc.2005). The stereotactic injections were done as previously described
(Beckervordersandforth et al., 2010).
Histology and Immunostaining
Histological analysis was done according to themanufacturer protocols for the
specific antibodies. The detailed protocols are presented in the Supplemental
Experimental Procedures.
FACS and mRNA Profiling
FACS of the particular neuronal populations and the mRNA profiling was per-
formed as previously described (Beckervordersandforth et al., 2010; Fischer
et al., 2011).
ChIP Assays
The qChIP experiments were performed as described elsewhere (Cuddapah
et al., 2009; Lee et al., 2006) with minor modifications described in the Supple-
mental Experimental Procedures.
Quantitative Analysis
Quantifications (proportions of reporter+ cells among particular cell types)
were done using ImageJ software to analyze confocal z stacks ensuring that
each cell would be counted separately and only once. At least 10 (per animal)
corresponding sections in compared animals were sampled and analyzed at
different medio-lateral positions to cover the entire extension of the OB or
SEZ, and the number of animals is indicated for every experiment. All results
are presented as mean and standard error of the mean. Statistical analysis
was performed in Microcal Origin 7.5 using ANOVA and Mann-Whitney U
test to test for significance.
Detailed experimental procedures are available in the Supplemental Exper-
imental Procedures on line.
ACCESSION NUMBERS
Array data have been submitted to Gene Expression Omnibus (GEO) under the
accession number GSE39362.
SUPPLEMENTAL INFORMATION
Supplemental Information for this article includes seven figures and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2013.07.002.
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